Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 27540591)

Published in Neurol Genet on August 04, 2016

Authors

Michaela F George1, Farren B S Briggs1, Xiaorong Shao1, Milena A Gianfrancesco1, Ingrid Kockum1, Hanne F Harbo1, Elisabeth G Celius1, Steffan D Bos1, Anna Hedström1, Ling Shen1, Allan Bernstein1, Lars Alfredsson1, Jan Hillert1, Tomas Olsson1, Nikolaos A Patsopoulos1, Philip L De Jager1, Annette B Oturai1, Helle B Søndergaard1, Finn Sellebjerg1, Per S Sorensen1, Refujia Gomez1, Stacy J Caillier1, Bruce A C Cree1, Jorge R Oksenberg1, Stephen L Hauser1, Sandra D'Alfonso1, Maurizio A Leone1, Filippo Martinelli Boneschi1, Melissa Sorosina1, Ingrid van der Mei1, Bruce V Taylor1, Yuan Zhou1, Catherine Schaefer1, Lisa F Barcellos1

Author Affiliations

1: Author affiliations are listed at the end of the article.

Articles citing this

A new dawn for genetic association studies in multiple sclerosis. Neurol Genet (2016) 0.85

Gene variants of adhesion molecules act as modifiers of disease severity in MS. Neurol Neuroimmunol Neuroinflamm (2017) 0.75

Pub-Med-dot-com, here we come! Neurol Genet (2016) 0.75

Articles cited by this

Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45

Vitamin D and multiple sclerosis. Lancet Neurol (2010) 3.15

Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet (2006) 3.13

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol (2009) 2.95

Body size and risk of MS in two cohorts of US women. Neurology (2009) 1.89

Genome-wide association study of Alzheimer's disease. Transl Psychiatry (2012) 1.88

Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet (2013) 1.55

Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009. J Neurol Neurosurg Psychiatry (2010) 1.52

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology (2009) 1.51

New perspectives in the natural history of multiple sclerosis. Neurology (2010) 1.50

Economic burden of multiple sclerosis: a systematic review of the literature. Pharmacoeconomics (2010) 1.48

Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain (2008) 1.37

Environmental factors in multiple sclerosis. Expert Rev Neurother (2013) 1.19

Genome-wide association study of severity in multiple sclerosis. Genes Immun (2011) 1.10

Smoking: effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord (2012) 1.08

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol (2009) 1.04

Identifying disease modifying genes in multiple sclerosis. J Neuroimmunol (2002) 1.02

Alpha-synuclein and familial Parkinson's disease. Mov Disord (2009) 1.01

Familial effects on the clinical course of multiple sclerosis. Neurology (2007) 1.00

IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation. J Immunol (2010) 0.99

The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur J Neurol (2007) 0.99

Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats. PLoS One (2012) 0.95

Adverse socioeconomic position during the life course is associated with multiple sclerosis. J Epidemiol Community Health (2014) 0.93

HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol (2004) 0.92

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain (2015) 0.90

A genome-wide association study of brain lesion distribution in multiple sclerosis. Brain (2013) 0.90

Burden of risk variants correlates with phenotype of multiple sclerosis. Mult Scler (2015) 0.88

Multiple loci comprising immune-related genes regulate experimental neuroinflammation. Genes Immun (2009) 0.86

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome. Genes Immun (2013) 0.83

Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology (1997) 0.83

Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat. PLoS One (2010) 0.82

Multiple linked quantitative trait loci within the Tmevd2/Eae3 interval control the severity of experimental allergic encephalomyelitis in DBA/2J mice. Genes Immun (2010) 0.81

Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition. Mult Scler (2010) 0.81

Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. PLoS One (2013) 0.80

The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset. J Neurol (2015) 0.78

Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. PLoS One (2013) 0.78